This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $449,900
Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers
CIHR · 2013 · Principal investigator
Optimizing Chronic Hepatitis C Treatment Using Pharmacogenomic Biomarkers
Principal investigators: Carleton, Bruce C; Kim, Richard B; Lee, Samuel S; Ross, Colin J
Keywords: Active Surveillance; Adverse Drug Reactions; Hepatitis C Therapy; Pharmacogenomics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.